OptumRx and Walgreens Partner to Improve Consumer Convenience, Cost Savings and Outcomes

Article

OptumRx and Walgreens are partnering to create a new pharmacy solution to meet consumers' changing prescription drug needs and help employers, health plans and their members achieve better health outcomes and greater cost savings.

PRESS RELEASE

EDEN PRAIRIE, Minn.

and DEERFIELD, Ill. (March 17, 2016)

— OptumRx and Walgreens are partnering to create a new pharmacy solution to meet consumers’ changing prescription drug needs and help employers, health plans and their members achieve better health outcomes and greater cost savings. OptumRx is UnitedHealth Group’s [NYSE: UNH] free-standing pharmacy care services business, managing more than one billion prescriptions annually. Walgreens is one of the nation’s largest drugstore chains and part of the Retail Pharmacy USA Division of Walgreens Boot Alliance, Inc. [Nasdaq: WBA].

Through a more convenient, accessible and connected pharmacy experience, the companies will collaborate to deliver clients and members enrolled in the program an integrated pharmacy care offering that:

  • Provides eligible OptumRx members the option to fill 90-day prescriptions at home delivery copay levels at any of Walgreens nearly 8,200 pharmacies nationwide or through OptumRx home delivery;

  • Produces higher treatment adherence rates and better patient outcomes by giving patients the choice of how to receive their medications along with 24/7 pharmacist availability;

  • Connects members to clinical guidance that addresses specific disease classes, such as diabetes, and increases drug adherence;

  • Enables OptumRx and Walgreens systems to better connect and communicate health data and analytics to ensure members receive the most effective prescription drugs at the right cost.

“By integrating Walgreens industry-leading in-store pharmacy capabilities and convenient retail locations with OptumRx’s advanced pharmacy care services, we expect to create significant value for our clients and members,” said Larry Renfro, chief executive officer of Optum. “We are excited to be working with Walgreens to create a new pharmacy solution that provides convenience and cost savings, and goes beyond filling prescriptions to deliver a more valuable pharmacy and health management experience for consumers.”

“OptumRx’s differentiated pharmacy care services model creating smarter health care connections will be a strong fit with the more than 27,000 Walgreens pharmacists who interact with and support millions of patients on a daily basis,” said Alex Gourlay, president of Walgreens. “Together, we will build upon our complementary capabilities and shared vision to offer this new pharmacy solution delivering true value to the customers that we serve.”

The joint pharmacy care offering is also designed to meet the goals of payers and health care sponsors seeking to better manage drug benefits and address the rising cost of care. By providing members with the choice of how to fill their 90-day maintenance medications, Walgreens and OptumRx can offer better access and prescription drug cost management to clients to help improve adherence rates for eligible members, resulting in better health outcomes and total health care cost savings.

OptumRx and Walgreens expect the new pharmacy solution to be available to commercial clients implementing new 90-day prescription benefit designs, beginning January 1, 2017.

Related Videos
Semaglutide Ozempic injection control blood sugar levels | Image Credit: myskin - stock.adobe.com
Image credit: motortion | stock.adobe.com - Young depressed woman talking to lady psychologist during session, mental health
Image credit:  JPC-PROD | stock.adobe.com - Choosing method of contraception : Birth control pills, an injection syringe, condom, IUD-method, on grey
Semaglutide Ozempic injection control blood sugar levels | Image Credit: myskin - stock.adobe.com
Health care provider examining MRI images of patient with multiple sclerosis -- Image credit: New Africa | stock.adobe.com
© 2024 MJH Life Sciences

All rights reserved.